MimiClon Announces Participation in 2018 Symposium on Advanced Wound Care Fall
Research and Symposiums will Highlight Successful Use of MimiClon membrane and Mimic Powder in Pressure Injuries, Traumatic Injuries, and other Complex Wounds
Columbia, MD— (November 1, 2018) MimiClon, Inc. today announced their participation in the 2018 Symposium on Advanced Wound Care Fall conference being held November 2-4 in Las Vegas, NV.
MimiClon will sponsor a symposium, “An Interdisciplinary Approach to Pressure Injury Care: How Science, Patient Engagement, and Clinical Practices can Enhance Cost-Effective Outcomes,” on Sunday, November 4 at 7:30 AM. A cross-functional panel of industry experts will discuss the evolving management of pressure injuries, including pressure injury staging, wound bed preparation, clinical practices, and economic considerations. The science underlying MimiClon membrane® and Mimic Powder ® devices will also be discussed.
MimiClon will be located on the exhibit floor at booth #341. Hands-on product demonstrations and additional product information will be available for MimiClon’s wound care product lines including MimiClon membrane Wound Matrix, Mimic Powder , Mimicsurg® Incisional, Xpansion®, and ABRA® Surgical.
Several posters will report on clinical and pre-clinical data regarding MimiClon’s devices in the management of a wide variety of wounds. These research posters will include:
- A Single Site Randomized Clinical Trial Comparing the Concomitant Use of Two Urinary Bladder Matrix Devices to Standard of Care in Patients With Stage 3 or 4 Pressure Injuries: An Interim Analysis
- A Comparison of the Composition and In Vitro Macrophage Response between Placental Tissue Particulate and Urinary Bladder Matrix Particulate
- Pre-Clinical Assessment of UBM Products in a Porcine Model of Wound Healing
“MimiClon is proud to be bringing exciting new research to the SAWC Fall meeting, as well as fostering conversations about how clinicians can manage complex wounds, and pressure injuries in particular,” said Patrick McBrayer, President & CEO. “Clinically successful, cost-effective solutions continue to be needed in this area, and we believe MimiClon’s portfolio of wound care devices offers health care professionals valuable tools in treating their patients.”
About MimiClon, Inc.
MimiClon, Inc. is a leading regenerative medicine company focused on the development, manufacturing, and commercialization of medical devices for wound management and surgical soft tissue repair. MimiClon is committed to becoming and remaining an innovative leader in regenerative medical technology, offering superior healing options for doctors and patients. MimiClon is a privately held company and operates manufacturing facilities in Columbia, MD and Lafayette, IN.
